Mollie Jewett, Ph.D.
Study (2021): “Lyme iDS: An Innovative Point-of-Care System for Reliable Diagnosis of Lyme Disease”
Study (2021): “Lyme iDS: An Innovative Point-of-Care System for Reliable Diagnosis of Lyme Disease”
Study (2021) “Impact of Borreliella burgdorferi infection, immunity & antibiotics on the host’s microbiome in a nonhuman primate model of Lyme disease”
Study (2021): "Breaking down the wall: Targeting peptidoglycan to treat and diagnose Lyme disease"
2023 © Copyright Global Lyme Alliance. All rights reserved.
Disclaimer: The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history. Global Lyme Alliance, Inc. makes no warranties of any kind regarding this Website, including as to the accuracy, completeness, currency or reliability of any information contained herein, and all such warranties are expressly disclaimed.